Clinical efficacy of split liver transplantation in the treatment of children with biliary atresia.
- Author:
Bin Sheng FU
1
,
2
,
3
,
4
,
5
;
Shu Hong YI
1
,
2
,
3
,
4
,
5
;
Hui Min YI
1
,
2
,
3
,
4
,
5
;
Xiao FENG
1
,
2
,
3
,
4
,
5
;
Tong ZHANG
1
,
2
,
3
,
4
,
5
;
Qing YANG
1
,
2
,
3
,
4
,
5
;
Ying Cai ZHANG
1
,
2
,
3
,
4
,
5
;
Jia YAO
1
,
2
,
3
,
4
,
5
;
Hui TANG
1
,
2
,
3
,
4
,
5
;
Kai Ning ZENG
1
,
2
,
3
,
4
,
5
;
Xiao Bin LI
1
,
2
,
3
,
4
,
5
;
Zhou YANG
1
,
2
,
3
,
4
,
5
;
Lei LYU
1
,
2
,
3
,
4
,
5
;
Gui Hua CHEN
1
,
2
,
3
,
4
,
5
;
Yang YANG
1
,
2
,
3
,
4
,
5
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Biliary Atresia/surgery*; Child; Child, Preschool; Creatinine; Female; Fibrinogen; Humans; Infant; Liver Transplantation/methods*; Living Donors; Male; Postoperative Complications/epidemiology*; Prothrombin; Retrospective Studies; Treatment Outcome
- From: Chinese Journal of Surgery 2022;60(10):900-905
- CountryChina
- Language:Chinese
- Abstract: Objective: To compare the clinical efficacy of split liver transplantation (SLT) and living donor liver transplantation(LDLT) in the treatment of children with biliary atresia. Methods: The clinical data of 64 children with biliary atresia who underwent SLT and 44 children who underwent LDLT from June 2017 to May 2022 at Liver Surgery & Liver Transplantation Center,the Third Affiliated Hospital of Sun Yat-sen University were retrospectively analyzed. Among the children who received SLT, there were 40 males and 24 females. The median age at transplantation was 8 months (range:4 to 168 months). Among the patients who received LDLT, there were 24 males and 20 females. The age at transplantation ranged from 4 to 24 months,with a median age of 7 months. Sixty-four children with biliary atresia were divided into two groups according to the SLT operation time: 32 cases in the early SLT group(June 2017 to January 2019) and 32 cases in the technically mature SLT group (February 2019 to May 2022). Rank sum test or t test was used to compare the recovery of liver function between the LDLT group and the SLT group,and between the early SLT group and the technically mature SLT group. The incidence of postoperative complications was compared by χ2 test or Fisher exact probability method. Kaplan-Meier method and Log-rank test were used for survival analysis. Results: The cold ischemia time(M (IQR)) (218 (65) minutes), intraoperative blood loss(175 (100) ml) and graft-to-recipient body weight ratio (3.0±0.7) in the LDLT group were lower than those in the SLT group(500 (130) minutes, 200 (250) ml, 3.4±0.8) (Z=-8.064,Z=-2.969, t=-2.048, all P<0.05). The cold ischemia time(457(158)minutes) and total hospital stay ((37.4±22.4)days) in the technically mature SLT group were lower than those in the early SLT group(510(60)minutes, (53.0±39.0)days).The differences were statistically significant (Z=-2.132, t=1.934, both P<0.05).The liver function indexes of LDLT group and SLT group showed unimodal changes within 1 week after operation. The peak values of ALT, AST, prothrombin time, activeated partial thromboplasting time, international normalized ratio, fibrinogen and creatinine all appeared at 1 day after operation, and the peak value of prothrombin activity appeared at 3 days after operation. All indicators returned to normal at 7 days after operation. The 1-,2-,and 3-year overall survival rates were 95.5% in LDLT group and 93.5% in the technically mature SLT group, and the difference was not statistically significant. The 1-,2-,and 3-year overall survival rates were 90.2% in the early SLT group and 93.5% in the technically mature SLT group, and there was no significant difference between the two groups(P>0.05). The main complications of the early SLT group were surgery-related complications(28.1%,9/32), and the main complications of the technically mature SLT group were non-surgery-related complications(21.9%,7/32). There were 5 deaths in the SLT group,including 4 in the early SLT group and 1 in the technically mature SLT group. Conclusion: The survival rate of SLT in the treatment of biliary atresia is comparable to that of LDLT.
